Veru Inc.(VERU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VERU Veru Inc.

盘后交易 04-27 19:46:50 EDT

2.34

+0.02

+0.86%

盘后2.30

-0.04-1.71%

17:04 EDT

最高2.42	最低2.30	成交量4.82万
今开2.33	昨收2.32	日振幅5.17%
总市值3,756万	流通市值3,388万	总股本1,605万
成交额11.33万	换手率0.33%	流通股本1,448万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VERU","market":"US","secType":"STK","nameCN":"Veru Inc.","latestPrice":2.34,"timestamp":1777320000000,"preClose":2.32,"halted":0,"volume":48177,"hourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":2.34,"latestTime":"17:04 EDT","volume":524,"amount":1213.8599907999999,"timestamp":1777323875463,"change":-0.04,"changeRate":-0.017094,"amplitude":0.042735},"delay":0,"changeRate":0.008620689655172422,"floatShares":14480400,"shares":16050392,"eps":-1.189798,"marketStatus":"盘后交易","change":0.02,"latestTime":"04-27 19:46:50 EDT","open":2.33,"high":2.42,"low":2.3,"amount":113279.1437709,"amplitude":0.051724,"askPrice":2.47,"askSize":900,"bidPrice":2.3,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-1.189798,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777334400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.32,"preHourTrading":{"tag":"盘前","latestPrice":2.3686,"preClose":2.32,"latestTime":"08:01 EDT","volume":10,"amount":23.683,"timestamp":1777291314279,"change":0.0486,"changeRate":0.020948,"amplitude":0.00431},"postHourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":2.34,"latestTime":"17:04 EDT","volume":524,"amount":1213.8599907999999,"timestamp":1777323875463,"change":-0.04,"changeRate":-0.017094,"amplitude":0.042735},"volumeRatio":0.964995,"impliedVol":0.6322,"impliedVolPercentile":0.216},"requestUrl":"/m/hq/s/VERU","defaultTab":"news","newsList":[{"id":"1168049288","title":"Veru Inc.启动恩博沙姆与司美格鲁肽联合疗法用于高质量减重的2B期平台临床试验，首位患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1168049288","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168049288?lang=zh_cn&edition=full","pubTime":"2026-03-09 20:36","pubTimestamp":1773059779,"startTime":"0","endTime":"0","summary":"Veru Inc.宣布，其用于实现高质量减重的恩博沙姆（enobosarm）与司美格鲁肽（semaglutide）联合疗法的2B期平台临床试验已完成首位患者入组。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4584","BK4183","BK4557","VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592110959","title":"Veru Inc.盘中异动 早盘急速拉升5.38%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592110959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592110959?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:33","pubTimestamp":1765981990,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日22时33分，Veru Inc.股票出现异动，股价快速上涨5.38%。截至发稿，该股报2.57美元/股，成交量9.8136万股，换手率0.61%，振幅4.51%。Veru Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Vyne Therapeutics Inc.、Aditxt, Inc.涨幅较大，Pmgc Holdings Inc.、Aditxt, Inc.、Vyne Therapeutics Inc.较为活跃，换手率分别为1010.96%、973.45%、250.03%，振幅较大的相关个股有Vyne Therapeutics Inc.、Aditxt, Inc.、Traws Pharma, Inc.，振幅分别为15.87%、14.79%、11.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121722331097a06e78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121722331097a06e78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4007","BK4557","VERU","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592911050","title":"Veru获准将其试验性减肥药与GLP-1药物联合使用进行试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2592911050","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592911050?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:57","pubTimestamp":1765979820,"startTime":"0","endTime":"0","summary":"药物开发商Veru于12月17日宣称，已获美国食品和药物管理局（FDA）支持，获准开展一项新试验，即将其试验性肥胖症药物enobosarm与当下流行的GLP-1药物进行联合用药试验。这一决定意味着enobosarm在肥胖症治疗领域的探索迈出重要一步，通过与GLP-1药物联合，有望发挥协同作用，为肥胖症患者提供更有效的治疗方案。Veru公司计划于明年初正式启动这项新的中期试验，以进一步评估联合用药的安全性、有效性及最佳剂量等关键指标，试验结果或将对肥胖症治疗领域产生重要影响，为众多患者带来新的治疗希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217215914a6ae55e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217215914a6ae55e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERU","BK4183","BK4584","BK4590","GLP","BK4557","BK4007","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584977296","title":"Veru Inc.盘中异动 大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584977296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584977296?lang=zh_cn&edition=full","pubTime":"2025-11-20 02:59","pubTimestamp":1763578797,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日02时59分，Veru Inc.股票出现异动，股价急速下跌5.06%。Veru Inc.股票所在的生物技术行业中，整体跌幅为0.94%。其相关个股中，Nuvation Bio Inc.、Kazia Therapeutics Limited、Annexon, Inc.涨幅较大，Kazia Therapeutics Limited、Clearmind Medicine Inc.、Can Fite Biopharma Ltd较为活跃，换手率分别为1485.15%、163.15%、60.27%，振幅较大的相关个股有Tempest Therapeutics, Inc.、Nuvation Bio Inc.、Biovie Inc C/Wts 08/08/2030，振幅分别为51.37%、50.21%、40.00%。Veru Inc.公司简介：Veru Inc是一家生物制药公司，拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120025958a704f5b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120025958a704f5b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERU","BK4183","BK4007","BK4584","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155375355","title":"Veru Inc. - 附带A系列和B系列权证的联合发行价格为每股3.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1155375355","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155375355?lang=zh_cn&edition=full","pubTime":"2025-10-30 20:03","pubTimestamp":1761825810,"startTime":"0","endTime":"0","summary":"Veru Inc. - 附带A系列和B系列权证的联合发行价格为每股3.00美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VERU","BK4584","BK4557","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166835000","title":"“减脂不减肌”：药企竞逐下一代减肥药新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1166835000","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166835000?lang=zh_cn&edition=full","pubTime":"2025-02-20 17:58","pubTimestamp":1740045485,"startTime":"0","endTime":"0","summary":"罗氏计划今年启动中期试验，将其与自研GLP-1减肥候选药CT-388联用。BiohavenBiohaven在一项早期肥胖试验中评估其靶向肌肉生长抑制素的药物taldefgrobep alfa。该药虽未改善脊髓性肌萎缩症患者的运动功能，但减少了总体脂肪量，并在去脂体重和骨密度方面优于安慰剂。公司将在男性肥胖患者的早期研究中评估安全性，数据预计2025年一季度公布。","market":"us","thumbnail":"https://community-static.tradeup.com/news/f13f2eb23080965f77e2c21530116841","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/f13f2eb23080965f77e2c21530116841"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"“减脂不减肌”：药企竞逐下一代减肥药新突破","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR","KROS","SRRK","REGN","VERU","LLY","ELAB","RHHBY","AZN"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2512827224","title":"Veru Inc.盘中异动 急速上涨5.05%报0.579美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512827224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512827224?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:56","pubTimestamp":1739984170,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时56分，Veru Inc.股票出现波动，股价急速上涨5.05%。截至发稿，该股报0.579美元/股，成交量53.3728万股，换手率0.36%，振幅5.05%。Veru Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Veru Inc.公司简介：Veru Inc是一家生物制药公司，拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220005610988b48c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220005610988b48c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4183","VERU","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512516732","title":"Veru Inc.盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512516732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512516732?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:32","pubTimestamp":1739896345,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时32分，Veru Inc.股票出现波动，股价急速上涨5.06%。截至发稿，该股报0.569美元/股，成交量124.164万股，换手率0.85%，振幅8.78%。Veru Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Veru Inc.公司简介：Veru Inc是一家生物制药公司，拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190032259627ac39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190032259627ac39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4183","VERU","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511652650","title":"Veru Inc.盘中异动 股价大跌5.09%报0.522美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511652650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511652650?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457068,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Veru Inc.股票出现波动，股价大幅下挫5.09%。截至发稿，该股报0.522美元/股，成交量152.217万股，换手率1.04%，振幅1.96%。Veru Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为970.17%、765.03%、89.78%，振幅较大的相关个股有Enliven Therapeutics, Inc.、Rezolute, Inc.、Edesa Biotech, Inc.，振幅分别为7.80%、4.53%、4.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322310998842b63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322310998842b63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERU","BK4557","BK4584","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104004542","title":"Veru 第一季度调整后每股收益$(0.07) 超过预期$(0.08)","url":"https://stock-news.laohu8.com/highlight/detail?id=1104004542","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104004542?lang=zh_cn&edition=full","pubTime":"2025-02-13 19:42","pubTimestamp":1739446968,"startTime":"0","endTime":"0","summary":"Veru  报告季度每股亏损$，超过了分析师一致预期的每股亏损$，超出12.5%。相比去年同期每股亏损$，增加了12.5%。以上内容来自Benzinga Earnings专栏，原文如下：Veru  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 12.5 percent. This is a 12.5 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511823546","title":"Veru(VERU.US)：2025年Q1财报实现营收0美元，前值为214.1万美元，预期值为298万美元；每股收益为-0.07美元，前值为-0.08美元，预期值为-0.08美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511823546","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511823546?lang=zh_cn&edition=full","pubTime":"2025-02-13 19:42","pubTimestamp":1739446935,"startTime":"0","endTime":"0","summary":"Veru(VERU.US)：2025年Q1财报实现营收0美元，前值为214.1万美元，预期值为298万美元；每股收益为-0.07美元，前值为-0.08美元，预期值为-0.08美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/13194248146640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157057844","title":"Veru公司2025财年第一季度GAAP每股收益为$(0.06)，好于预期$(0.07)，现金及现金等价物为2660万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157057844","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157057844?lang=zh_cn&edition=full","pubTime":"2025-02-13 19:33","pubTimestamp":1739446411,"startTime":"0","endTime":"0","summary":"Veru公司公布季度每股亏损$，较分析师普遍预期的$高出14.29%。与去年同期的每股亏损$相比，增长了25%。以上内容来自Benzinga Earnings专栏，原文如下：Veru  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 14.29 percent. This is a 25 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Veru公司2025财年第一季度GAAP每股收益为$(0.06)，好于预期$(0.07)，现金及现金等价物为2660万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380942","title":"Veru Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380942?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:50","pubTimestamp":1739285410,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时50分，Veru Inc.股票出现异动，股价大幅下挫5.15%。Veru Inc.股票所在的生物技术行业中，整体跌幅为1.52%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2370.36%、645.02%、277.64%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为40.26%、33.04%、33.02%。Veru Inc.公司简介：Veru Inc是一家生物制药公司，拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211225010abcb0a77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211225010abcb0a77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","VERU","BK4183","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509614773","title":"Veru Inc.盘中异动 快速跳水5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509614773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509614773?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:30","pubTimestamp":1738956645,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时30分，Veru Inc.股票出现异动，股价快速下挫5.18%。截至发稿，该股报0.551美元/股，成交量136.703万股，换手率0.93%，振幅8.33%。Veru Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Veru Inc.公司简介：Veru Inc是一家生物制药公司，拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208033045a23d60ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208033045a23d60ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","VERU","BK4183","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509565352","title":"Veru Inc.盘中异动 急速上涨5.00%报0.588美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509565352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509565352?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:33","pubTimestamp":1738787622,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时33分，Veru Inc.股票出现波动，股价大幅拉升5.00%。截至发稿，该股报0.588美元/股，成交量251.646万股，换手率1.72%，振幅8.75%。Veru Inc.股票所在的生物技术行业中，整体涨幅为2.25%。Veru Inc.公司简介：Veru Inc是一家生物制药公司，拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206043342abc3c826&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206043342abc3c826&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","VERU","BK4584","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509286491","title":"Veru Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509286491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509286491?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:57","pubTimestamp":1738702628,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时57分，Veru Inc.股票出现异动，股价快速下跌5.00%。Veru Inc.股票所在的生物技术行业中，整体涨幅为1.46%。其相关个股中，Mink Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1968.51%、997.59%、592.78%，振幅较大的相关个股有Azitra Inc、Mink Therapeutics, Inc.、Omega Therapeutics, Inc.，振幅分别为123.99%、80.03%、60.13%。Veru Inc.公司简介：Veru Inc是一家生物制药公司，拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205045708abc26e47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205045708abc26e47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","BK4557","VERU","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508639144","title":"Veru Inc.盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508639144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508639144?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:52","pubTimestamp":1738594339,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时52分，Veru Inc.股票出现波动，股价快速拉升5.27%。截至发稿，该股报0.585美元/股，成交量57.5427万股，换手率0.39%，振幅8.10%。Veru Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Veru Inc.公司简介：Veru Inc是一家生物制药公司，拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225219abc10c20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225219abc10c20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","BK4557","VERU","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507562478","title":"Veru Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507562478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507562478?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:37","pubTimestamp":1738247823,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时37分，Veru Inc.股票出现异动，股价大幅跳水5.10%。截至发稿，该股报0.580美元/股，成交量51.2556万股，换手率0.35%，振幅5.56%。Veru Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为789.58%、134.25%、112.73%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Kazia Therapeutics Limited、Tectonic Therapeutic, Inc.，振幅分别为28.90%、28.25%、24.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302237039876b255&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302237039876b255&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4557","BK4183","VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507631266","title":"Veru Inc.盘中异动 早盘快速拉升5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507631266?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:31","pubTimestamp":1738161066,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时31分，Veru Inc.股票出现波动，股价大幅上涨5.53%。截至发稿，该股报0.550美元/股，成交量48.0583万股，换手率0.33%，振幅0.02%。Veru Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Veru Inc.公司简介：Veru Inc是一家生物制药公司，拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223106a23366cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223106a23366cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4183","VERU","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506514939","title":"Veru Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506514939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506514939?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074693,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Veru Inc.股票出现异动，股价大幅上涨5.10%。截至发稿，该股报0.668美元/股，成交量52.5319万股，换手率0.36%，振幅1.09%。Veru Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Veru Inc.公司简介：Veru Inc是一家生物制药公司，拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822313498756b68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822313498756b68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","VERU","BK4584","BK4183"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://verupharma.com","stockEarnings":[{"period":"1week","weight":-0.0492},{"period":"1month","weight":0.0131},{"period":"3month","weight":-0.1714},{"period":"6month","weight":-0.3895},{"period":"1year","weight":-0.5775},{"period":"ytd","weight":0.0841}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Veru Inc.于1971年在威斯康星州成立。公司是一家临床后期生物制药公司，专注于研发治疗心脏代谢和炎症性疾病的新药。该公司的药物开发计划包括两个晚期新化学实体，enobosarm和sabizabulin。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.00255},{"month":2,"riseRate":0.470588,"avgChangeRate":0.061533},{"month":3,"riseRate":0.352941,"avgChangeRate":-0.044098},{"month":4,"riseRate":0.588235,"avgChangeRate":0.128031},{"month":5,"riseRate":0.5,"avgChangeRate":0.006227},{"month":6,"riseRate":0.3125,"avgChangeRate":-0.035854},{"month":7,"riseRate":0.411765,"avgChangeRate":-0.01072},{"month":8,"riseRate":0.411765,"avgChangeRate":-0.001858},{"month":9,"riseRate":0.411765,"avgChangeRate":-0.009009},{"month":10,"riseRate":0.352941,"avgChangeRate":-0.029885},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.015125},{"month":12,"riseRate":0.235294,"avgChangeRate":0.066456}],"exchange":"NASDAQ","name":"Veru Inc.","nameEN":"Veru Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Veru Inc.(VERU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Veru Inc.(VERU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Veru Inc.,VERU,Veru Inc.股票,Veru Inc.股票老虎,Veru Inc.股票老虎国际,Veru Inc.行情,Veru Inc.股票行情,Veru Inc.股价,Veru Inc.股市,Veru Inc.股票价格,Veru Inc.股票交易,Veru Inc.股票购买,Veru Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Veru Inc.(VERU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Veru Inc.(VERU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}